Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.16353 | 47 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.12974 | 48 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.13062 | 48 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.0137 | 46 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.06231 | 47 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.19307 | 47 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.19264 | 47 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.11478 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.08042 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.09194 | 47 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.10879 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.03112 | 46 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.27798 | 52 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.11465 | 47 |